Targeting Classical EGFR Mutations in Lung Cancer: Twenty Years of Progress and Beyond.

Uehara Y, Hatano H, Zhang JT, Han J, Chua KLM, Saw SPL

Open source

DOI
10.3390/cancers18152401
Published
2026 Jul 25
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18152401,
  title = {Targeting Classical EGFR Mutations in Lung Cancer: Twenty Years of Progress and Beyond.},
  author = {Uehara Y and Hatano H and Zhang JT and Han J and Chua KLM and Saw SPL},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18152401},
  url = {https://doi.org/10.3390/cancers18152401}
}

RIS

TY  - JOUR
TI  - Targeting Classical EGFR Mutations in Lung Cancer: Twenty Years of Progress and Beyond.
AU  - Uehara Y
AU  - Hatano H
AU  - Zhang JT
AU  - Han J
AU  - Chua KLM
AU  - Saw SPL
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18152401
UR  - https://doi.org/10.3390/cancers18152401
ER  -

APA

Y, U., H, H., JT, Z., J, H., KLM, C., & SPL, S. (2026). Targeting Classical EGFR Mutations in Lung Cancer: Twenty Years of Progress and Beyond.. Cancers. https://doi.org/10.3390/cancers18152401

Source records